(Q43156838)

14 November 2017

title

Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease (English)

1 reference

14 November 2017

1 reference

Sang J Na

1

1 reference

14 November 2017

Anthony G DiLella

2

1 reference

14 November 2017

Edward V Lis

3

1 reference

14 November 2017

Keith Jones

4

1 reference

14 November 2017

David M Levine

5

1 reference

14 November 2017

David J Stone

6

1 reference

14 November 2017

J F Hess

7

1 reference

14 November 2017

publication date

19 February 2010

1 reference

14 November 2017

published in

Neurochemical Research

1 reference

14 November 2017

volume

35

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

761-772

1 reference

Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism

14 November 2017

cites work

1 reference

12 December 2020

The role and expression of the protocadherin-alpha clusters in the CNS.

1 reference

12 December 2020

The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.

1 reference

12 December 2020

Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs

1 reference

12 December 2020

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

1 reference

12 December 2020

Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum

1 reference

12 December 2020

Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry

1 reference

12 December 2020

Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems

1 reference

12 December 2020

Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease

1 reference

12 December 2020

Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways

1 reference

12 December 2020

Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver

1 reference

12 December 2020

The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined byin situ hybridization

1 reference

12 December 2020

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

1 reference

12 December 2020

Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease.

1 reference

12 December 2020

Toxin-induced models of Parkinson's disease

1 reference

12 December 2020

Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum

1 reference

12 December 2020

The pathogenesis of cell death in Parkinson's disease--2007.

1 reference

12 December 2020

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

12 December 2020

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

1 reference

12 December 2020

Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons

1 reference

12 December 2020

Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat

1 reference

12 December 2020

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

12 December 2020

What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?

1 reference

12 December 2020

Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development

1 reference

12 December 2020

PANTHER: a library of protein families and subfamilies indexed by function

1 reference

12 December 2020

Microarrays in Parkinson's disease: a systematic approach

1 reference

12 December 2020

Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death.

1 reference

12 December 2020

10.1007/S11064-010-0133-3

Identifiers

DOI

1 reference

Dimensions Publication ID

14 November 2017

1010250757

0 references

1 reference